Xenikos Enrolls First Patient In Global Pivotal Phase 3 Study Evaluating T-Guard® In Patients With Steroid-Refractory Acute Graft-Versus-Host Disease

Press/Media

Period27 Jun 2022

Media coverage

1

Media coverage

  • TitleXenikos Enrolls First Patient In Global Pivotal Phase 3 Study Evaluating T-Guard® In Patients With Steroid-Refractory Acute Graft-Versus-Host Disease
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date27/06/22
    PersonsJohn Levine